Cytokine gene transfer for the treatment of cancer

C Bruyns1, C Gérard, T Velu

  • 1Department of Medical Genetics, Université Libre de Bruxelles, Brussels, Belgium.

Nouvelle Revue Francaise D'Hematologie
|January 1, 1994
PubMed

Insights

Gene therapy using cytokine gene transfer in tumor cells shows promise for cancer treatment. This approach stimulates an immune response, offering protection against tumors and potential therapeutic benefits for existing cancers.

Area of Science:

  • Oncology
  • Immunology
  • Gene Therapy

Background:

  • Significant advancements in understanding cancer pathogenesis and its relationship with the immune system.
  • Cancer gene therapy is exploring immune system manipulation to create systemic anti-tumor responses.

Purpose of the Study:

  • To investigate the potential of cytokine gene transfer for cancer treatment.
  • To evaluate the induction of immune responses against cancer through gene therapy.

Main Methods:

  • Transferring cytokine genes into tumor cells.
  • Assessing the induced immune response in animal models.
  • Evaluating the efficacy against existing and subsequent tumor cell injections.

Main Results:

  • Cytokine gene transfer into tumor cells successfully induced an immune response.
  • This immune response provided protection against subsequent tumor cell challenges.
  • The approach demonstrated efficacy in treating pre-existing tumors in animal models.

Conclusions:

  • Cytokine gene transfer is a promising strategy for cancer immunotherapy.
  • Experimental findings support the development of clinical protocols for human cancer treatment using this gene therapy approach.

Related Concept Videos

Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...